Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of this research study is to determine if an investigational dendritic cell vaccine, called pp65 DC, is effective for the treatment of a specific type of brain tumor called glioblastoma (GBM) when given with stronger doses of routine chemotherapy.
Epistemonikos ID: 1a6c7c608f8158c2e6fbcaed3a05137124c4f404
First added on: May 12, 2024